These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30419238)

  • 1. Oxymatrine prevents the development of monocrotaline-induced pulmonary hypertension via regulation of the N
    Dai G; Li B; Xu Y; Zeng Z; Yang H
    Eur J Pharmacol; 2019 Jan; 842():338-344. PubMed ID: 30419238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.
    Pei Y; Ma P; Wang X; Zhang W; Zhang X; Zheng P; Yan L; Xu Q; Dai G
    Eur J Pharmacol; 2011 Sep; 666(1-3):165-72. PubMed ID: 21641341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats.
    Zhang W; Zhang J; Liu YK; Liu J; Wang X; Xu Q; Wang Y; Xu X; Dai G
    Eur J Pharmacol; 2014 Dec; 745():29-35. PubMed ID: 25310909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effect of oxymatrine on chronic heart failure and ADMA metabolism pathway in isoproterenol-induced chronic heart failure in rats].
    Wang Y; Xu YH; Xiong AQ; Yuan YN; Zheng P; Ma P; Dai GD; Xu QB
    Zhongguo Zhong Yao Za Zhi; 2014 Feb; 39(3):471-7. PubMed ID: 24946550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
    Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
    Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxymatrine prevents hypoxia- and monocrotaline-induced pulmonary hypertension in rats.
    Zhang B; Niu W; Xu D; Li Y; Liu M; Wang Y; Luo Y; Zhao P; Liu Y; Dong M; Sun R; Dong H; Li Z
    Free Radic Biol Med; 2014 Apr; 69():198-207. PubMed ID: 24440469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethylarginine dimethylaminohydrolase 1 deficiency aggravates monocrotaline-induced pulmonary oxidative stress, pulmonary arterial hypertension and right heart failure in rats.
    Wang D; Li H; Weir EK; Xu Y; Xu D; Chen Y
    Int J Cardiol; 2019 Nov; 295():14-20. PubMed ID: 31402164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
    Pullamsetti S; Kiss L; Ghofrani HA; Voswinckel R; Haredza P; Klepetko W; Aigner C; Fink L; Muyal JP; Weissmann N; Grimminger F; Seeger W; Schermuly RT
    FASEB J; 2005 Jul; 19(9):1175-7. PubMed ID: 15827267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
    Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
    Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Bhat L; Hawkinson J; Cantillon M; Reddy DG; Bhat SR; Laurent CE; Bouchard A; Biernat M; Salvail D
    Eur J Pharmacol; 2017 Sep; 810():92-99. PubMed ID: 28577964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Yuyama H; Fujimori A; Sanagi M; Koakutsu A; Sudoh K; Sasamata M; Miyata K
    Eur J Pharmacol; 2004 Aug; 496(1-3):129-39. PubMed ID: 15288584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of nicotinamide and L-arginine against monocrotaline-induced pulmonary hypertension in rats: gender dependence.
    Sztormowska-Achranowicz K; Jankowski Z; Kocić I
    Pharmacol Rep; 2020 Oct; 72(5):1334-1346. PubMed ID: 32632916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats.
    Tang B; Chen GX; Liang MY; Yao JP; Wu ZK
    Int J Cardiol; 2015 Feb; 180():134-41. PubMed ID: 25438234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL; Guan RJ; Xu QH; Wu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
    Chen L; Xiao J; Li Y; Ma H
    Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):1-7. PubMed ID: 21381494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.